Stockify
Search Contact
Menu

Pharma

Anglo-French Drugs & Industries Ltd

Unlisted in snapshot Compare companies
Historical snapshot ₹1,601.25 Recorded

Not a live quote.

Historical data

Price history

Recorded snapshot values in Indian rupees. These prices are historical.

– 6 recorded prices
Recorded prices in INR · 6 months ₹1,601.25
First
₹1,601.25
Low
₹1,601.25
High
₹1,601.25
Last
₹1,601.25
View recorded prices
Snapshot price data · 6 months
DatePrice (INR)
₹1,601.25
₹1,601.25
₹1,601.25
₹1,601.25
₹1,601.25
₹1,601.25

Company profile

Overview

Anglo-French Drugs & Industries Limited (AFDIL) operates as a pharmaceutical company. The Company manufactures and processes vitamins, anti-epileptics, anti-oxidants, sleep inducing agents, cold and cough preparations, protein food supplements, digestive enzymes, and calcium supplements. AFDIL serves clients worldwide.

Quality At AFDIL, Quality is of foremost concern. In nearly 100 years of operations, we have continuously remained one of India’s most trustworthy manufacturers. Our commitment to quality is managed by current and validated technology, the best resources, effective cGMP, efficient and trained personnel, excellent production design and continuous in-process monitoring.

Sector
Manufacturing · Pharma
ISIN
INE570E01016
Face Value
₹10
Depository
NSDL, CDSL
RTA
integrated registry management services private
HQ
No. 41, 3rd Cross, 5th Block, Rajajinagar, Bengaluru – 560 010, Karnataka , India.

Reported figures

Financials

Figures and periods shown as reported in the snapshot.

Profit and loss
Profit and loss · up to five captured years
Metric20262025202220212020
Revenue129.4118166.1154.8131.7
Expense99.6105156.7137.4117.8
EBITDA29.8139.417.413.9
Other Cost75.17.27.810.3
Profit Before Taxes22.87.92.29.63.6
Tax Expense−0.10.70.42.10.6
Profit after Taxes22.87.21.97.53.1
Other Income (Exp.)0.1−0.10−0.3−0.2
Income (Net of Taxes)22.97.11.97.53.1
Outstanding Share0.110.110.190.130.12
Earning per Share (₹)20262165.82.7
Revenue Growth %9.66%−28.96%7.3%17.54%1.46%
EBITDA Margin %23.03%11.02%5.66%11.24%10.55%
Net Margin %17.7%6.02%1.14%4.84%2.35%
EPS Growth %225.81%287.5%175.86%114.81%−485.71%
Balance sheet
Balance sheet · up to five captured years
Metric20262025202220212020
Cash & Cash Equivalent0.40.22.11.20.6
Non Current Asset27.231.719.214.216.6
Current Asset178.1160.575.879.475.9
Total Asset205.7192.497.194.893.1
Equity Share Capital1.11.11.31.31.2
Reserves146.4123.717.614.85.4
Total Equity147.5124.818.916.16.5
Non Current Liability611.330.22113.5
Current Liability52.256.44857.773
Total Liabilities199.767.6101.278.786.6
Total Equity & Liability205.7192.497.194.893.1
Cash flow
Cash flow · up to five captured years
Metric20262025202220212020
Operating Activity0.11.913.74.515.1
Investing Activity−0.344.7−9.1−0.8−2.7
Financing Activity0.4−46.5−4.8−3.3−12.4
Net Cash Flow0.20.1−0.10.40

Source material

Documents

Reports link to the original publisher’s files.

Original Stockify profile

Search Stockify